Summary of Patient Demographics.

Note: Data listed as total number of patients, unless otherwise noted. C-SVR: co-infected sustained virologic responders; C-NR: co-infected non-responders; CDT: co-infected deferring treatment; MST: mono-infected starting treatment; MDT: mono-infected deferring treatment; BMI: body mass index; NSAID: Non-Steroidal Anti-inflammatory drug; und: undetectable or below the lower limit of detection (LLOD). 1LLOD is <615 IU/mL; 2LLOD is <20 IU/mL. †One patient in this group had an HCV RNA level of 673 IU/mL at follow-up, but still achieved SVR. ‡Excludes steroids administered topically or intranasally. *Fisher’s exact p-value.